Lista de obras - Matteo Simonelli - Dominio Público Uruguay

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

artículo científico publicado en 2013

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

artículo científico publicado en 2006

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

artículo científico publicado en 2017

Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top"

scientific article published on 21 June 2018

Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings.

artículo científico publicado en 2010

Herpes infections in breast cancer patients treated with adjuvant chemotherapy

artículo científico publicado en 2006

High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review.

artículo científico publicado en 2007

Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.

artículo científico publicado en 2017

Imaging biomarkers in primary brain tumours

artículo científico publicado en 2014

Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.

artículo científico publicado en 2016

Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas

artículo científico publicado en 2010

Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma

artículo científico publicado en 2014

Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment

artículo científico publicado en 2018

Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors

artículo científico publicado en 2019

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

artículo científico publicado en 2017

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study

scientific article published on 14 September 2020

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

artículo científico publicado en 2015

Neuro-Oncology During the COVID-19 Outbreak: A Hopeful Perspective at the End of the Italian Crisis

artículo científico publicado en 2020

Neutrophils in Gliomas.

artículo científico publicado en 2017

Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

artículo científico publicado en 2017

Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.

artículo científico publicado en 2016

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study

artículo científico publicado en 2020

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

artículo científico publicado en 2014

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours

artículo científico publicado en 2012

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

artículo científico publicado en 2012

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

artículo científico publicado en 2016

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

artículo científico publicado en 2017

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

artículo científico publicado en 2010

Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

artículo científico publicado en 2017

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

artículo científico publicado en 2014

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

artículo científico publicado en 2017

Reproducibility of the WHO classification of thymomas: practical implications

artículo científico publicado en 2012

Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.

artículo científico publicado en 2011

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

artículo científico publicado en 2011

Role of myeloid cells in the immunosuppressive microenvironment in gliomas

scientific article published on 19 October 2019

Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study

artículo científico publicado en 2016

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

artículo científico publicado en 2011

Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.

artículo científico

Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review

artículo científico publicado en 2012

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy.

artículo científico publicado en 2016

Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

artículo científico publicado en 2013

Lista de obras de Matteo Simonelli

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top"

Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings.

Herpes infections in breast cancer patients treated with adjuvant chemotherapy

High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review.

Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.

Imaging biomarkers in primary brain tumours

Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.

Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas

Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma

Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment

Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

Neuro-Oncology During the COVID-19 Outbreak: A Hopeful Perspective at the End of the Italian Crisis

Neutrophils in Gliomas.

Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

Reproducibility of the WHO classification of thymomas: practical implications

Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

Role of myeloid cells in the immunosuppressive microenvironment in gliomas

Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.

Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy.

Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma